Immunization, Hib3 in Peru
Peru: Immunization, Hib3 was 80.0% in 2024. ▲ Rising
Immunization, Hib3 in Peru, 1998–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children ages 12-23 months.
Analysis
The most recent figure for immunization, hib3 in Peru is 80.0%, measured in 2024.
Compared with earlier readings it is down 4.8% on the previous year and down 9.1% over ten years.
Over the whole period, immunization, hib3 in Peru peaked at 96.0% in 2004 and was at its lowest, 12.0%, in 1998.
Peru ranks 142nd of 191 countries on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 27 years of available data.
Immunization, Hib3 in Peru, year by year
| Year | % of children ages 12-23 months | Change |
|---|---|---|
| 1998 | 12.0% | — |
| 1999 | 28.0% | +133.3% |
| 2000 | 43.0% | +53.6% |
| 2001 | 38.0% | -11.6% |
| 2002 | 40.0% | +5.3% |
| 2003 | 41.0% | +2.5% |
| 2004 | 96.0% | +134.1% |
| 2005 | 94.0% | -2.1% |
| 2006 | 94.0% | +0.0% |
| 2007 | 93.0% | -1.1% |
| 2008 | 93.0% | +0.0% |
| 2009 | 93.0% | +0.0% |
| 2010 | 93.0% | +0.0% |
| 2011 | 91.0% | -2.2% |
| 2012 | 95.0% | +4.4% |
| 2013 | 88.0% | -7.4% |
| 2014 | 88.0% | +0.0% |
| 2015 | 90.0% | +2.3% |
| 2016 | 90.0% | +0.0% |
| 2017 | 89.0% | -1.1% |
| 2018 | 89.0% | +0.0% |
| 2019 | 88.0% | -1.1% |
| 2020 | 72.0% | -18.2% |
| 2021 | 82.0% | +13.9% |
| 2022 | 82.0% | +0.0% |
| 2023 | 84.0% | +2.4% |
| 2024 | 80.0% | -4.8% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 20.0% | 12.0% | 28.0% | 2 |
| 2000s | 72.5% | 38.0% | 96.0% | 10 |
| 2010s | 90.1% | 88.0% | 95.0% | 10 |
| 2020s | 80.0% | 72.0% | 84.0% | 5 |
Countries ranked near Peru
More health data for Peru
- Un projection of annual infant deaths, annual growth rate -1.88 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5045 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,235 deaths per 1,000 people (2090)
- Number of infants who die before age 1 782 deaths (2100)
- Population ages 50-54, male, annual growth rate 2.36 % change on previous year (2025)
- Population ages 50-54, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 50-54, male, per capita 0.0277 units per person (2025)
- Population ages 55-59, female, annual growth rate 3.12 % change on previous year (2025)
- Population ages 55-59, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 55-59, female, per capita 0.0232 units per person (2025)
Frequently asked questions
- What is immunization, hib3 in Peru?
- Immunization, hib3 in Peru was 80.0% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, hib3 recorded in Peru?
- The highest recorded value was 96.0% in 2004.
- What is the lowest immunization, hib3 recorded in Peru?
- The lowest recorded value was 12.0% in 1998.
- How does Peru rank for immunization, hib3?
- Peru ranks 142nd out of 191 countries with data for 2024.
- Is immunization, hib3 rising or falling in Peru?
- Over the last ten years it is down 9.1%. The long-run trend across the full record is rising.
- Where does this Peru data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, Hib3 (% of children ages 12-23 months). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 27 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.